Barrett, R., Kuzawa, C. W., McDade, T. & Armelagos, G. J. Emerging and re-emerging infectious diseases: the third epidemiologic transition. Annu. Rev. Anthropol. 27, 247–271 (1998).
McMichael, A. J. Human culture, ecological change, and infectious disease: are we experiencing history’s fourth great transition? Ecosyst. Health 7, 107–115 (2001).
Horby, P. W., Hoa, N. ., Pfeiffer, D. U. & Wertheim, H. F. L. Drivers of emerging zoonotic infectious diseases. Confronting Emerging Zoonoses (eds Yamada, A., Kahn, L., Kaplan, B., Monath, T., Woodall, J. & Conti, L.) (Springer Press, Tokyo, 2014).
Wilcox, B. A. & Gubler, D. J. Disease ecology and the global emergence of zoonotic pathogens. Environ. Health Prev. Med. 10, 263–272 (2005).
Jones, K. E. et al. Global trends in emerging infectious diseases. Nature 451, 990–994 (2008).
Wilcox, B. A. & Colwell, R. R. Emerging and reemerging infectious diseases: biocomplexity as an interdisciplinary paradigm. Ecohealth 2, 244–257 (2005).
Hooper, D. et al. A global synthesis reveals biodiversity loss as a major driver of ecosystem change. Nature 486, 105–108 (2012).
Keesing, F., Holt, R. D. & Ostfeld, R. S. Effects of species diversity on disease risk. Ecol. Lett. 9, 485–498 (2006).
Keesing, F. et al. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 468, 647–652 (2010).
Woo, P. C. et al. Molecular diversity of coronaviruses in bats. Virology 351, 180–187 (2006).
Wolfe, N. D., Daszak, P., Kilpatrick, A. M. & Burke, D. S. Bushmeat hunting, deforestation, and prediction of zoonotic disease emergence. Emerg. Infect. Dis. 11, 1822–1827 (2005).
Lai, M. M. C. & Cavanagh, D. The molecular biology of coronaviruses. Adv. Virus Res. 48, 1–100 (1997).
Ziebuhr, J. The Coronavirus replicase. Curr. Top. Microbiol. Immunol. 287, 57–94 (2005).
Brian, D. A. & Baric, R. S. Coronavirus genome structure and replication. Curr. Top. Microbiol. Immunol. 287, 1–30 (2005).
Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454 (2003).
Walls, A. et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 531, 114–117 (2016).
Hoffmann, M., Hofmann-Winkler, H. & Poehlmann, S. Priming time: how cellular proteases arm coronavirus spike proteins, in Activation of viruses by host proteases. (eds Eva Boettger –Friebertsaeuser, Wolfgang Gartner, Hans Dieter Klenk) 71-–98 (Springer, Cham, 2018).
Li, F., Li, W., Farzan, M. & Harrison, S. C. Interactions between Sars coronavirus and its receptors. Adv. Exp. Med. Biol. 581, 229–234 (2006).
Hoffmann, M. et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 1–10 (2020).
Hoffmann, M. et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. Preprint at BioRxiv https://doi.org/10.1101/2020.01.31.929042 (2020).
Snijder, E. J., Decroly, E. & Ziebhur, J. The nonstructural proteins directing coronavirus RNA synthesis and processing. Adv. Virus Res. 96, 59–126 (2016).
Gao, Y. et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368, 779–782 (2020).
Yin, W. et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Preprint at BioRxiv https://doi.org/10.1101/2020.04.08.032763 (2020).
Zhang, X. et al. Nucleocapsid protein of SARS.CoV activates Interleukin-6 expression through cellular transcription factor NF-kB. Virology 365, 324–335 (2007).
Ge, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535–538 (2013).
Menachery, V. D. et al. SARS-like WIV1-CoV poised for human emergence. Proc. Natl Acad. Sci. USA 113, 3048–3053 (2016).
Yang, X.-L. et al. Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus. J. Virol. 90, 3253–3256 (2016).
Li, W. et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 310, 676–679 (2005).
Lau, S. K. P. et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl Acad. Sci. USA 102, 14040–14045 (2005).
Tang, X. C. et al. Prevalence and genetic diversity of coronaviruses in bats from China. J. Virol. 80, 7481–7490 (2006).
Cui, J., Li, F. & Shi, Z. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181–192 (2019).
Zhou, H. et al. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the Spike protein. Curr. Biol. 30, 2196–2203 (2020).
Wang, N. et al. Serological evidence of bat SARS-related Coronavirus infection in humans, China. Virol. Sin. 33, 104–107 (2018).
Joyjinda, Y. et al. First complete genome sequence of human coronavirus HKU1 from a non hill bat guano miner in Thailand. Microbiol. Resour. Announc. 8, 1–3 (2019).
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. & Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452 (2020).
Guan, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276–278 (2003).
Centers for Disease Control. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders: Guangdong Province, China. MMWR 52, 986–987 (2003).
Normile, D. Viral DNA match spurs China’s civet roundup. Science 303, 292 (2004).
Watts, J. China culls wild animals to prevent new SARS threat. Lancet 363, 134 (2004).
Xu, H. F. et al. An epidemiologic investigation on infection with severe acute respiratory syndrome coronavirus in wild animals traders in Guangzhou. Zhonghua Yu Fang Yi Xue Za Zhi 38, 81–83 (2004).
Wu, D. et al. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J. Virol. 79, 2620–26255 (2005).
Kan, B. et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J. Virol. 79, 11892–11900 (2005).
Wang, L. F. et al. Review of bats and SARS. Emerg. Infect. Dis. 12, 1834–1840 (2006).
Tommy, T. L. et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature 583, 282–285 (2020).
Liu, P. et al. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLOS Pathog. 16, 1–13 (2020).
Damas, J. et al. Broad host range of SARS-CoV-2 predicted Comparative and structural analysis of ACE2 in vertebrates. Preprint at BioRxiv https://doi.org/10.1101/2020.04.16.045302 (2020).
Lee, J. et al. No evidence of coronaviruses or other potentially zoonotic viruses in Sunda pangolins (Manis javanica) entering the wildlife trade via Malaysia. Preprint at BioRxiv https://doi.org/10.1101/2020.06.19.158717 (2020).
Xiang, X. Sichuan villager capture 33 bats isolated from their homes and have eaten them. Morning Post (February, 2020).
Xu, D. Huanan market has more than a dozen of wildlife animals. China Business Network (March, 2020).
Zhang, L., Zhu, G., Jones, G. & Zhang, S. Conservation of bats in China: problems and recommendations. Oryx 43, 179–182 (2009).
Yu, W. B., Tang, G. D., Zhang, L. & Corlett, R. T. Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2/HCoV-19) using whole genomic data. Zool. Res. 41, 247–257 (2020).
Chen, W. et al. SARS-associated coronavirus transmitted from human to pig. Emerg. Infect. Dis. 11, 446–448 (2005).
Ling, H. Beijing Xinfa wholesale market temporarily closed! Imported salmon case board detected with new coronavirus. Science and Technology Daily Beijing (2020).
Josephine M. Coronavirus: China’s first confirmed COVID-19 case traced back to November 17th. South China Morning Post (2020).
Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
Cohen, J. Wuhan seafood market may not be source of novel virus spreading globally. Science 367, 234–235 (2020).
Deslandes, A. et al. SARS-CoV-2 was already spreading in France in late December 2019. Int. J. Antimicrob. Agents https://doi.org/10.1016/j.ijantimicag.2020.106006 (2020).
Forster, P., Forster, L., Renfrew, C. & Forster, M. M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc. Natl Acad. Sci. USA 117, 9241–9243 (2020).
Korber, B. et al. Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. Preprint at BioRxiv https://doi.org/10.1101/2020.04.29.069054 (2020).
Bhattacharyya, C., et al. Global spread of SARS-CoV-2 subtype with spike protein mutation D614G is shaped by human genomic variations that regulate expression of TMPRSS2 and MX1 genes. Preprint at BioRxiv https://doi.org/10.1101/2020.05.04.075911 (2020).
Zhang, L. et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. Preprint at BioRxiv https://doi.org/10.1101/2020.06.12.148726 (2020).
Balboni, A., Palladini, A., Bogliani, G. & Battilani, M. Detection of a virus related to betacoronaviruses in Italian greater horseshoe bats. Epidemiol. Infect. 139, 216–219 (2011).
Mousavizadeh, L. & Ghasemi, S. Genotype and phenotype of COVID-19: Their role in patghogenesis. J. Microbiol. Immunol. Infection, 1–5 https://doi.org/10.1016/j.jmil.2020.03.022 (2020).
Ellinghaus D. et al. Genome-wide association study of severe COVID-19 with respiratory failure. N. Engl. J. Med., 1–13 https://doi.org/10.1056/NEJMoa2020283 (2020).
Zeberg, H. & Paabo, S. The major genetic risk factor for severe COVID-19 is inherited from Neandertals. Preprint at BioRxiv https://doi.org/10.1101/2020.07.03.186296 (2020).
Drexler, J. F. et al. Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences. J. Virol. 84, 11336–11349 (2010).
Pfefferle, S. et al. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats. Ghana. Emerg. Infect. Dis. 15, 1377–1384 (2009).
Quan, P. L. et al. Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria. mBio 1(4), e00208–e00210 (2010).
Ren, W. et al. Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. J. Gen. Virol. 87, 3355–3359 (2006).
Wu, Z. et al. ORF8-related genetic evidence for Chinese horseshoe bats as the source of human severe acute respiratory syndrome coronavirus. J. Infect. Dis. 213, 579–583 (2015).
Lau, S. K. P. et al. Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination. J. Virol. 89, 10532–10547 (2015).
Source: Ecology - nature.com
